Department of Microbiology,
Graduate School of Biomedical Sciences
Paul E. Leon has not added Biography.
If you are Paul E. Leon and would like to personalize this page please email our Author Liaison for assistance.
Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin.
Journal of virology Dec, 2014 | Pubmed ID: 25210195
Preexisting human antibodies neutralize recently emerged H7N9 influenza strains.
The Journal of clinical investigation Mar, 2015 | Pubmed ID: 25689254
Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies.
Antimicrobial agents and chemotherapy Jul, 2015 | Pubmed ID: 25941218
Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection.
Immunity Jan, 2016 | Pubmed ID: 26789921
Broadly-Reactive Neutralizing and Non-neutralizing Antibodies Directed against the H7 Influenza Virus Hemagglutinin Reveal Divergent Mechanisms of Protection.
PLoS pathogens Apr, 2016 | Pubmed ID: 27081859
Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection.
Cell host & microbe Jun, 2016 | Pubmed ID: 27281570
Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2016 | Pubmed ID: 27647907
Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice.
Nature communications 10, 2017 | Pubmed ID: 29018261
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。